Co-occurrence of neurofibromatosis type 1 and pseudoachondroplasia - a first case report. 2023

Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, 1085, Hungary.

Neurofibromatosis type 1 and pseudoachondroplasia are both rare autosomal dominant disorders, caused by pathogenic mutations in NF1 and COMP genes, respectively. Both neurofibromin 1 and cartilage oligomeric matrix protein (COMP) play a role in the development of the skeleton. Carrying both germline mutations has not been previously reported; however, it can affect the developing phenotype. The index patient, an 8-year-old female presented with several skeletal and dermatologic anomalies resembling the coexistence of multiple syndromes. Her mother had dermatologic symptoms characteristic for neurofibromatosis type 1, and her father presented with distinct skeletal anomalies. NGS-based analysis revealed a heterozygous pathogenic mutation in genes NF1 and COMP in the index patient. A previously unreported heterozygous variant was detected for the NF1 gene. The sequencing of the COMP gene revealed a previously reported, pathogenic heterozygous variant that is responsible for the development of the pseudoachondroplasia phenotype. Here, we present the case of a young female carrying pathogenic NF1 and COMP mutations, diagnosed with two distinct heritable disorders, neurofibromatosis type 1 and pseudoachondroplasia. The coincidence of two monogenic autosomal dominant disorders is rare and can pose a differential diagnostic challenge. To the best of our knowledge, this is the first reported co-occurrence of these syndromes.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009456 Neurofibromatosis 1 An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS). Peripheral Neurofibromatosis,Recklinghausen Disease of Nerve,von Recklinghausen Disease,Cafe-au-Lait Spots with Pulmonic Stenosis,Molluscum Fibrosum,NF1 (Neurofibromatosis 1),Neurofibromatosis I,Neurofibromatosis Type 1,Neurofibromatosis Type I,Neurofibromatosis, Peripheral Type,Neurofibromatosis, Peripheral, NF 1,Neurofibromatosis, Peripheral, NF1,Neurofibromatosis, Type 1,Neurofibromatosis, Type I,Pulmonic Stenosis with Cafe-au-Lait Spots,Recklinghausen Disease, Nerve,Recklinghausen's Disease of Nerve,Recklinghausens Disease of Nerve,Watson Syndrome,von Recklinghausen's Disease,Cafe au Lait Spots with Pulmonic Stenosis,Neurofibromatoses, Peripheral,Neurofibromatoses, Type I,Neurofibromatosis, Peripheral,Peripheral Neurofibromatoses,Pulmonic Stenosis with Cafe au Lait Spots,Syndrome, Watson,Type 1 Neurofibromatosis,Type 1, Neurofibromatosis,Type I Neurofibromatoses,Type I, Neurofibromatosis,von Recklinghausens Disease
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000130 Achondroplasia An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001) Severe Achondroplasia with Developmental Delay and Acanthosis Nigricans,Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans,SADDAN,SADDAN Dysplasia,Skeleton-Skin-Brain Syndrome,Achondroplasias,Dysplasia, SADDAN,Dysplasias, SADDAN,SADDAN Dysplasias,SADDANs,Skeleton Skin Brain Syndrome,Skeleton-Skin-Brain Syndromes,Syndrome, Skeleton-Skin-Brain,Syndromes, Skeleton-Skin-Brain

Related Publications

Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
June 2024, Molecular syndromology,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
April 2020, Familial cancer,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
January 2024, Nephron,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
January 2015, Journal of pediatric neurosciences,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
May 1997, Anales espanoles de pediatria,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
January 2013, Srpski arhiv za celokupno lekarstvo,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
January 2020, Indian journal of pathology & microbiology,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
February 2022, Experimental and therapeutic medicine,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
January 1996, Pediatric dentistry,
Sára Pálla, and Pálma Anker, and Klára Farkas, and Dóra Plázár, and Sándor Kiss, and Péter Marschalkó, and Zsuzsanna Szalai, and Judit Bene, and Kinga Hadzsiev, and Zoltán Maróti, and Tibor Kalmár, and Márta Medvecz
May 2014, Multiple sclerosis and related disorders,
Copied contents to your clipboard!